免責事項: 本サイトは、FDA、ClinicalTrials.gov、PubMed、SEC EDGAR などの公式公開データを一般参考用に集約するものであり、医学的助言、診断、治療推奨、投資助言を構成しません。

臨床試験

Neurofeedback Therapy Added to Cognitive Behavioural Therapy-Based Psychoeducation for Test Anxiety Among Undergraduate Students: A Randomised Controlled Trial

NCT: NCT07860489 · COMPLETED

NCT識別子NCT07860489
ステータスCOMPLETED
開始日2026-04-20
完了2026-07-03
SponsorInternational Islamic University Malaysia (OTHER)
First posted
Last updated

概要

The goal of this clinical trial was to learn whether adding neurofeedback therapy to cognitive behavioural therapy (CBT)-based psychoeducation could reduce test anxiety in university students more than CBT-based psychoeducation alone. The main questions it aimed to answer were: 1. Did adding neurofeedback to CBT-based psychoeducation produce a greater reduction in test anxiety than CBT-based psychoeducation alone? 2. Did test anxiety levels change from before the intervention to the middle and end of the intervention period? Researchers compared two groups. One group received CBT-based psychoeducation together with neurofeedback training, while the other group received CBT-based psychoeducation alone. Participants were randomly assigned to one of the two groups. Participants: * Completed screening for test anxiety using the Westside Test Anxiety Scale (WTAS). * Completed the Test Anxiety Inventory (TAI) before, during, and after the intervention. * Received CBT-based psychoeducation on test anxiety and coping strategies. * Participants assigned to the neurofeedback group also completed a baseline EEG assessment and received 10 sessions of EEG-based neurofeedback training targeting high-beta2 activity at the F4 electrode site. * Practised CBT-based coping strategies during the intervention period. The main outcome was change in Test Anxiety Inventory scores across the three assessment points and whether the pattern of change differed between the two study groups.

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。

↑